\
&
Contact us
\
&
Contact us
This was 7 months ago
LocationBrussels
This event will bring together key stakeholders from industry, research, and public authorities to discuss opportunities under the Innovation Fund, one of Europe’s most ambitious programs for supporting innovation in clean technologies.
There will be representatives from DG CLIMATE ACTION of the European Commission and CINEA (European Climate, Infrastructure and Environment Executive Agency), who will provide valuable insights into the fund’s objectives, application process, and upcoming calls for proposals.
Participation is free, but places are limited.
Information on the full agenda and registration can be found here .
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
